One of the out-patient rehabilitation alternatives for people in Billings battling with opioid dependence and addiction is called opioid maintenance therapy. Some centers and doctors are certified to dispense specific medications to opioid addicted individuals, many that are opioid-based themselves and are habit forming. With low enough amounts however, the client doesn't experience being high but also does not experience acute cravings and is not in opioid withdrawal. Methadone is the first drug used for this sole purpose, but there are a few more options currently to choose from.
Methadone is an opiate and can be taken at an outpatient medical center certified to administer the med, that is taken daily in liquid or pill form. The price of the med is about $150 monthly. Buprenorphine is also an opioid based med, and is a pill often taken every other day. But unlike Methadone which can only be administered in highly well-regulated medical centers, Buprenorphine can be prescribed and dispensed in doctor's offices. The price monthly of buprenorphine is around $300 monthly for the generic of the medication. There is also a type of buprenorphine that contains naloxone, which is a drug that reverses the effects of opioids. A person consuming this version of the drug, also known as Suboxone, would find it harder to feel high from opioids if they relapsed while taking the drug. It too is taken every day, and costs about $450 monthly. Naltrexone is another medication used in opioid maintenance therapy, but unlike the other drugs mentioned it's an opioid blocker and isn't an opiate. A person has the choice to take this medication as a monthly shot, which is called Vivitrol. As an opioid blocker, it prevents someone from experience high feelings from opioids, and therefore lowers the risk associated with relapse. This daily injection costs anywhere from $1000 to $1200 per month.
There are 2 Drug and Alcohol Treatment Programs offering this service in Billings, MT
For All Alcohol and Drug Rehab Programs In Billings, Click Here.